Platinum-Taxane doublet chemotherapy
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for Platinum-Taxane doublet chemotherapy, covering 2025-07-15 to 2025-07-15. Get the full timeline:
Most recent: Clinical Trial Update: A Study Comparing Niraparib Versus Platinum-Taxane Doublet Chemotherapy as Neoadjuvant Treatment in Participants With Homologous Recombination-Deficient Stage III/IV Ovarian Cancer (COHORT-C) [Phase 2]